Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of Histone Deacetylase Inhibitor-Regulated Gene Expression in Cancer Cells
Anderly C. Chüeh, Janson W.T. Tse, Lars Tögel, et al.
Antioxidants and Redox Signaling (2014) Vol. 23, Iss. 1, pp. 66-84
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions
Rohit Loomba, T. Jake Liang
Gastroenterology (2017) Vol. 152, Iss. 6, pp. 1297-1309
Open Access | Times Cited: 516
DNA Hypomethylating Drugs in Cancer Therapy
Takahiro Sato, Jean‐Pierre J. Issa, Patricia Kropf
Cold Spring Harbor Perspectives in Medicine (2017) Vol. 7, Iss. 5, pp. a026948-a026948
Open Access | Times Cited: 135
A Novel View of the Adult Stem Cell Compartment From the Perspective of a Quiescent Population of Very Small Embryonic-Like Stem Cells
Mariusz Z. Ratajczak, Janina Ratajczak, Malwina Suszyńska, et al.
Circulation Research (2017) Vol. 120, Iss. 1, pp. 166-178
Open Access | Times Cited: 123
HDAC inhibitors: A new promising drug class in anti-aging research
E. G. Pasyukova, Alexander Vaiserman
Mechanisms of Ageing and Development (2017) Vol. 166, pp. 6-15
Closed Access | Times Cited: 90
The Cancer Epigenome: Exploiting Its Vulnerabilities for Immunotherapy
Helen Loo Yau, Ilias Ettayebi, Daniel D. De Carvalho
Trends in Cell Biology (2018) Vol. 29, Iss. 1, pp. 31-43
Closed Access | Times Cited: 90
Platinum(IV) anticancer agents; are we en route to the holy grail or to a dead end?
Dan Gibson
Journal of Inorganic Biochemistry (2021) Vol. 217, pp. 111353-111353
Closed Access | Times Cited: 90
Inhibition of histone deacetylase 6 alleviates neuropathic pain via direct regulating post-translation of spinal STAT3 and decreasing downstream C-C Motif Chemokine Ligand 7 synthesis
Zhexi Chi, Bo Lu, Rongjun Liu, et al.
Journal of Neuroinflammation (2025) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancer
David B. Page, Harry D. Bear, Sangeetha Prabhakaran, et al.
npj Breast Cancer (2019) Vol. 5, Iss. 1
Open Access | Times Cited: 74
Epigenetic changes in gastric cancer induction by Helicobacter pylori
Bahman Yousefi, Maryam Mohammadlou, Maryam Abdollahi, et al.
Journal of Cellular Physiology (2019) Vol. 234, Iss. 12, pp. 21770-21784
Closed Access | Times Cited: 71
Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma
Ping Zhang, Mingzhi Zhang
Clinical Epigenetics (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 68
Can changes in histone acetylation contribute to memory formation?
José P. López‐Atalaya, Ángel Barco
Trends in Genetics (2014) Vol. 30, Iss. 12, pp. 529-539
Closed Access | Times Cited: 67
Class I histone deacetylase inhibitor suppresses vasculogenic mimicry by enhancing the expression of tumor suppressor and anti-angiogenesis genes in aggressive human TNBC cells
Aparna Maiti, Qianya Qi, Xuan Peng, et al.
International Journal of Oncology (2019)
Open Access | Times Cited: 64
Transcriptional Selectivity of Epigenetic Therapy in Cancer
Takahiro Sato, Matteo Cesaroni, Woonbok Chung, et al.
Cancer Research (2016) Vol. 77, Iss. 2, pp. 470-481
Open Access | Times Cited: 61
A Pan-Histone Deacetylase Inhibitor Enhances the Antitumor Activity of B7-H3–Specific CAR T Cells in Solid Tumors
Xinyuan Lei, Zhanpeng Ou, Zhao‐hui Yang, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 13, pp. 3757-3771
Open Access | Times Cited: 42
Epigenetic modulation of cytokine expression in gastric cancer: influence on angiogenesis, metastasis and chemoresistance
María Elena Reyes, Victoria Pulgar, Carolina Vivallo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Enhanced Solubility, Permeability and Anticancer Activity of Vorinostat Using Tailored Mesoporous Silica Nanoparticles
Anand Kumar Meka, Laura J. Jenkins, Mercedes Dávalos-Salas, et al.
Pharmaceutics (2018) Vol. 10, Iss. 4, pp. 283-283
Open Access | Times Cited: 57
Histone Deacetylases and Their Inhibitors in Cancer Epigenetics
Kelly N. Hassell
Diseases (2019) Vol. 7, Iss. 4, pp. 57-57
Open Access | Times Cited: 53
Deletion of intestinal Hdac3 remodels the lipidome of enterocytes and protects mice from diet-induced obesity
Mercedes Dávalos-Salas, Magdalene K. Montgomery, Camilla M. Reehorst, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 52
ATF3 Repression of BCL-XL Determines Apoptotic Sensitivity to HDAC Inhibitors across Tumor Types
Anderly C. Chüeh, Janson W.T. Tse, Michael Dickinson, et al.
Clinical Cancer Research (2017) Vol. 23, Iss. 18, pp. 5573-5584
Open Access | Times Cited: 51
Vorinostat in autophagic cell death: A critical insight into autophagy-mediated, -associated and -dependent cell death for cancer prevention
Srimanta Patra, Prakash Priyadarshi Praharaj, Daniel J. Klionsky, et al.
Drug Discovery Today (2021) Vol. 27, Iss. 1, pp. 269-279
Open Access | Times Cited: 39
The Modulatory Effects of Fatty Acids on Cancer Progression
Annemarie J. F. Westheim, Lara M. Stoffels, Ludwig J. Dubois, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 280-280
Open Access | Times Cited: 14
Targeting apoptosis in clear cell renal cell carcinoma
Adam Kowalewski, Jędrzej Borowczak, Mateusz Maniewski, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116805-116805
Open Access | Times Cited: 5
Reciprocal Modulation of Histone Deacetylase Inhibitors Sodium Butyrate and Trichostatin A on the Energy Metabolism of Breast Cancer Cells
Mariana Figueiredo Rodrigues, Érika Carvalho, Paula Pezzuto, et al.
Journal of Cellular Biochemistry (2014) Vol. 116, Iss. 5, pp. 797-808
Closed Access | Times Cited: 42
Dysregulation of histone deacetylases in carcinogenesis and tumor progression: a possible link to apoptosis and autophagy
Srimanta Patra, Debasna Pritimanjari Panigrahi, Prakash Priyadarshi Praharaj, et al.
Cellular and Molecular Life Sciences (2019) Vol. 76, Iss. 17, pp. 3263-3282
Closed Access | Times Cited: 39
Epigenetic Regulation of Leukocyte Inflammatory Mediator Production Dictates Staphylococcus aureus Craniotomy Infection Outcome
Zachary Van Roy, Wen Shi, Gunjan Kak, et al.
The Journal of Immunology (2023) Vol. 211, Iss. 3, pp. 414-428
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top